Bloodwork question about exemestane. Baseline, six weeks in, and the numbers moved in a direction I did not expect.
The animal data is stronger than the human data and the human data is not nothing, it is just small.
The effect size I actually noticed is roughly a third of what the write-ups imply, and it took six weeks to be sure.
I would rather have a narrow conclusion and be right than a broad one and be interesting.
Mechanism is not outcome, and a plausible pathway is the most expensive kind of evidence there is.
Curious whether the popular dose has any basis or is just the convenient one.
Underdosing and tolerance are indistinguishable from the inside, and everyone picks the flattering explanation.
Same here.
Narrow conclusion, briefly right. Broad conclusion, interestingly wrong. I know which I keep choosing.
Loose evidence and no evidence are different, and people overcorrect in both directions.